Oxidative stress and endothelial damage in chronic heart failure: effects of carvedilol and bisoprolol

被引：0
|
作者：
Chin, BSP
Nuttall, S
Gibbs, CR
Kendall, M
Blann, AD
Lip, GYH
机构：
[1] Univ Birmingham, Dept Med, City Hosp NHS Trust, Birmingham, W Midlands, England
[2] Univ Birmingham, Div Med Sci, Birmingham, W Midlands, England
来源：
EUROPEAN HEART JOURNAL | 2001年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：639 / 639
页数：1
相关论文
共 50 条
  • [21] Initiation of treatment with carvedilol or bisoprolol and changes in body fat mass in patients with chronic heart failure
    Lainscak, M.
    Keber, I.
    Anker, S. D.
    EUROPEAN HEART JOURNAL, 2005, 26 : 443 - 443
  • [22] Comparative Effectiveness of Bisoprolol, Carvedilol, and Metoprolol Succinate in Patients with Heart Failure and Chronic Kidney Disease
    Huang, Cheng-Wei
    Yu, Albert S.
    Zhou, Hui
    Pak, Katherine
    Shaw, Sally F.
    Shi, Jiaxiao
    Broder, Benjamin I.
    Sim, John J.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2025, 20 (01): : 136 - 138
  • [23] Comparative dose titration responses to the introduction of bisoprolol or carvedilol in stable chronic systolic heart failure
    Hamaad, Ali
    Lip, Gregory Y. H.
    Nicholls, Deborah
    MacFadyen, Robert J.
    CARDIOVASCULAR DRUGS AND THERAPY, 2007, 21 (06) : 437 - 444
  • [24] Carvedilol, Bisoprolol, and Metoprolol Use in Patients With Coexistent Heart Failure and Chronic Obstructive Pulmonary Disease
    Su, Vincent Yi-Fong
    Chang, Yu-Sheng
    Hu, Yu-Wen
    Hung, Man-Hsin
    Ou, Shuo-Ming
    Lee, Fa-Yauh
    Chou, Kun-Ta
    Yang, Kuang-Yao
    Perng, Diahn-Warng
    Chen, Tzeng-Ji
    Liu, Chia-Jen
    MEDICINE, 2016, 95 (05)
  • [25] Comparative Dose Titration Responses to the Introduction of Bisoprolol or Carvedilol in Stable Chronic Systolic Heart Failure
    Ali Hamaad
    Gregory Y. H. Lip
    Deborah Nicholls
    Robert J. MacFadyen
    Cardiovascular Drugs and Therapy, 2007, 21 : 437 - 444
  • [26] Effects of carvedilol in elderly patients with chronic heart failure
    Bristow, MR
    Gilbert, EM
    Packer, M
    Colucci, WS
    Lukas, MA
    Court, M
    Fowler, MB
    Cohn, JN
    CIRCULATION, 1997, 96 (08) : 3228 - 3228
  • [27] Differences between bisoprolol and carvedilol in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized trial
    Lainscak, Mitja
    Podbregar, Matej
    Kovacic, Dragan
    Rozman, Janez
    von Haehling, Stephan
    RESPIRATORY MEDICINE, 2011, 105 : S44 - S49
  • [28] The effects of carvedilol and nebivolol on oxidative stress status in patients with non-ischaemic heart failure
    Karabacak, Mustafa
    Dogan, Abdullah
    Tayyar, Senol
    Bas, Hasan Aydin
    KARDIOLOGIA POLSKA, 2015, 73 (03) : 201 - 206
  • [29] Bisoprolol in the treatment of chronic heart failure
    De Groote, Pascal
    Ennezat, Pierre-Vladimir
    Mouquet, Frederic
    VASCULAR HEALTH AND RISK MANAGEMENT, 2007, 3 (04) : 431 - 439
  • [30] Switching from carvedilol to bisoprolol ameliorates adverse effects in heart failure patients with dizziness or hypotension
    Taniguchi, Tatsunori
    Ohtani, Tomohito
    Mizote, Isamu
    Kanzaki, Machiko
    Ichibori, Yasuhiro
    Minamiguchi, Hitoshi
    Asano, Yoshihiro
    Sakata, Yasushi
    Komuro, Issei
    JOURNAL OF CARDIOLOGY, 2013, 61 (5-6) : 417 - 422
12345